Results 101 to 110 of about 19,566 (247)

Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A

Haematologica
Desmopressin increases plasma factor VIII and von Willebrand factor in non-severe hemophilia A (Hem A) and type 1 von Willebrand disease (VWD), following intravenous infusions, subcutaneous injections or nasal spray.
Alessandro Gringeri, Pier Mannuccio Mannucci, Michele Gringeri, Giancarlo Castaman, Flora Peyvandi   +4 more
doaj   +1 more source

Clinical Features And Laboratory Patterns In A Cohort Of Consecutive Argentinian Patients With Von Willebrand's Disease [PDF]

, 2001
Background and Objectives. von Willebrand's disease (vWD) is a bleeding disorder with variable clinical expression. Our aim was to classify patients with vWD and to determine the phenotype in their relatives. Design and Methods.
Blanco, A. N., Farias, Cristina Elena, Kempfer, Ana Catalina, Lazzari, María Ángela, Meschengieser, S. S., Salviu, M. J., Woods, Adriana Inés   +6 more
core  

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib [PDF]

, 2017
The Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib induces platelet dysfunction and causes increased risk of bleeding. Off-target inhibition of Tec is believed to contribute to platelet dysfunction and other side-effects of ibrutinib.
Appleby, Niamh, Bruce, David, Bye, Alex P., Desborough, Michael J., Gibbins, Jon M., Hildyard, Catherine A. T., Hughes, Craig E., Kriek, Neline, Nock, Sophie H., Sage, Tanya, Unsworth, Amanda J.   +10 more
core   +2 more sources

Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B [PDF]

, 2019
Tim Preijers, Lisette M. Schütte, Marieke J.H.A. Kruip, Marjon H. Cnossen, Frank W.G. Leebeek, Reinier M. van Hest, Ron A. A. Mathôt   +6 more
openalex   +1 more source

Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease. [PDF]

, 2014
Acquired Hemophilia A (AHA) is a rare bleeding diathesis characterized by the development of autoantibodies against factor VIII (FVIII). About half of the cases are idiopathic and the other half are associated with autoimmune diseases, postpartum ...
Celestino, F, De Carlo, F, Di Stasi, SM, Verri, C   +3 more
core   +2 more sources

Endothelial Function and Coagulant Factors in Growth Hormone-Treated Hypopituitary Adults Receiving Desmopressin [PDF]

, 2003
J. C. Smith, H. A. Lane, James Lewis, SG Dann, Jonathan Goodfellow, Peter W. Collins, Marc Evans, M. F. Scanlon, Jeffrey S. Davies   +8 more
openalex   +1 more source

Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience

Endocrine Connections
Omissions or delays in desmopressin can result in serious patient harm in patients with arginine vasopressin deficiency (AVP-D), formally known as cranial diabetes insipidus.
Muhammad Fahad Arshad, Sam Solanki, Luka Dancyger-Stevens, Madushani Karunanayaka, Ee-Wen Loh, Kyaw Naing Htoon, Mohanad Turki, Alia Munir   +7 more
doaj   +1 more source

Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria [PDF]

, 2005
夜間多尿に伴う夜間頻尿の患者12例(男性10例, 女性2例, 平均年齢67歳)に対して, 酢酸デスモプレシン(l0μg)鼻腔内噴霧を2週間行い, その治療効果について検討した.治療前後の排尿状況, 尿の性状, 使用状況, 合併症などを調査した結果, 平均夜間尿量は928mlから469mlに, 平均夜間尿回数は4.8回から2.8回に減少した.平均早朝尿浸透圧は420から598mOsm/kgに上昇し, 平均尿中Na濃度は100から140mEq/lに上昇した.平均血中Na濃度は141から135mEq ...
北原, 光輝, 大森, 孝平, 寺田, 直樹, 岡田, 能幸, 新垣, 隆一郎, 西村, 一男, 金子, 嘉志   +6 more
core  

Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus [PDF]

, 2022
Ilja Dubinski, Susanne Bechtold‐Dalla Pozza, Heinrich Schmidt   +2 more
openalex   +1 more source

Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis? [PDF]

, 2002
Ertuğrul Özal, Erkan Kuralay, Hakan Bingöl, Faruk Cíngöz, Süleyman Ceylan, Harun Tatar   +5 more
openalex   +1 more source